The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Share News (TSTL)

Share Price Information for Tristel (TSTL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 452.50
Bid: 445.00
Ask: 460.00
Change: 5.00 (1.12%)
Spread: 15.00 (3.371%)
Open: 447.50
High: 452.50
Low: 447.50
Prev. Close: 447.50
TSTL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disinfectant Demand Pushes Up Tristel's Interim Profit, Hikes Dividend

Mon, 22nd Feb 2021 10:59

(Alliance News) - Tristel PLC on Monday reported a higher half-year profit, with overseas revenue particularly high, as the pandemic lifted demand for disinfectants.

The company, which makes infection prevention and contamination control products, posted a GBP3.1 million pretax profit for the six months ended December 31, up 11% from GBP2.8 million the year before.

Revenue increased 15% to GBP16.8 million from GBP14.6 million, including an 8% rise in UK revenue thanks to an 18% rise in cash surface disinfection revenue to GBP1.5 million from GBP800,000.

Overseas revenue increased by 20% to GBP10.0 million from GBP8.3 million, including a 19% rise in Tristel medical device decontamination revenue to GBP8.7 million plus a 67% rise in cash surface disinfection revenue to GBP500,000.

"Tristel product sales in all countries have been adversely affected as patient examinations have been deferred. Cache product sales have been positively impacted because hospitals rushed to purchase any type of disinfectant. During the second half of 2020 this phenomenon came to an end and now we are observing a more considered approach to the selection of surface disinfectants," explained Chair Bruno Holthof.

The company lifted its interim dividend per share by 12% to 2.62 pence from 2.34p a share the year before.

Chief Executive Paul Swinney said: "The second half will be the third consecutive six-month period to be impacted by the pandemic. Unlike the previous two halves, we have started this one in lockdown in many of our key markets. Sales of our medical device disinfectants during the first seven weeks of 2021 are lower than budget due to the impact of Covid-19 on patient examinations. We are very confident that by the end of calendar 2021, the ENT, gynaecology, urology, cardiology, and ophthalmology departments where our products are used will have returned to pre-pandemic levels of activity. Whether this will happen in the UK and Europe before our June year-end is unclear at present.

"However, the growth prospects for the group are as strong as ever and we look to the future with confidence."

Shares in Tristel were up 0.1% at 600.55p in London on Monday morning.

By Anna Farley; annafarley@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
12 Oct 2015 09:47

Infection Control Firm Tristel Multiples Dividend As Profit Rises

Read more
12 Oct 2015 05:47

GET READY: Jupiter Fund Management At 0700 BST

Read more
5 Oct 2015 14:59

Earnings, Trading Statements Calendar - Week Ahead

Read more
18 Jun 2015 11:22

LONDON MIDDAY BRIEFING: Eyes Turn To Latest Greek Crisis Meeting

Read more
18 Jun 2015 10:38

WINNERS & LOSERS: Fresnillo, Randgold Resources Up As Gold Price Rises

Read more
18 Jun 2015 07:40

Tristel Shares Rise As It Reveals 3 Pence Special Dividend

Read more
21 May 2015 11:19

LONDON MIDDAY BRIEFING: Royal Mail Outlook Causes Concerns

Read more
21 May 2015 10:45

WINNERS & LOSERS: Miners Boosted By Chinese Stimulus Hopes

Read more
21 May 2015 07:39

Tristel Upgrades Profit Guidance As It Trades Ahead Of Expectations

Read more
25 Feb 2015 08:41

Tristel Raises Dividend 63% After Strong First-Half Profit Rise

Read more
11 Nov 2014 09:57

Tristel Says Another Study Has Shown Benefits Of Its Wipes Study

Read more
4 Nov 2014 15:16

Tristel chairman Soler trims stake

The chairman of hospital infection control experts Tristel sold a small chunk of his shares in the company late on Monday. Francisco Soler sold 250,000 shares in the dividend-paying company at a price of 75p per share on 31 October and on 3 November 2014 sold 100,000 more at the same price to gross

Read more
3 Nov 2014 18:08

DIRECTOR DEALINGS: Tristel Non-Executive Chairman Sells Shares

Read more
13 Oct 2014 14:46

Tristel boosts full-year profit after restructuring

Tristel, a manufacturer of infection prevention and contamination control products, saw profit for the year to end of June rise after undertaking a set of restructuring measures. An 18-month restructuring plan, the creation of new products and investment in the disinfection market led the firm to be

Read more
13 Oct 2014 09:23

Tristel Quadruples Dividend As It Swings To Profit On Restructuring

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.